SUMMARY Significant loss of neurons in the pedunculopontine nucleus pars compacta (PPNc), a putative cholinergic nucleus involved in modulating somatic motor activities, has been demonstrated in progressive supranuclear palsy (PSP) and Parkinson's disease but not in Alzheimer's disease. A morphometric study of this nucleus was performed in two cases of PSP and in a cohort of cases of Parkinson's disease, Alzheimer's disease, senile dementia of Alzheimer type (SDAT), and age-matched controls. In PSP a significant 60% neuronal loss in PPNc was associated with neurofibrillary tangles in 40 to 64% of the remaining neurons. In Parkinson's disease there was a significant decrease in cell numbers and density by 53 and 51%, respectively, with Lewy bodies involving 6 to 39% of all neurons. In Alzheimer's disease and SDAT, large neurons were reduced by 29 and 33-8%, respectively, with tangles in 9 to 38% of the remaining cells. The selective affection of this putative cholinergic nucleus in PSP and Parkinson's disease appears to be related to motor dysfunctions in these disorders.
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Material and methods
The sample included five groups of patients, the major clinical and neuropathological data of which are given in the The PPNc from each case was sampled at two levels from serially sectioned formalin-fixed, paraffin-embedded blocks of the brainstem cut at 5-7 pm stained with cresyl violet, haematoxylin and eosin, Bodian's silver and congo red stains. PPNc neurons of more than 20 gm with prominent nucleoli and abundant Nissl substance were counted in cresyl violet sections under 400-fold magnification using an ocular micrometer. The area of the NPPc was calculated by counting the number of fields of 0 53 x 0 75 mm (0-395 sqmm). Lewy bodies and tangles were counted within the same fields. Statistical significance was evaluated by Student's t test.
Results
While in controls the mean number of large neurons in NPPc was 9147, (SEM 172) with a mean cell density of 58-3, (1-2) cells/mm2, in Parkinson's disease the mean neuronal number was 48 5, 1-44 with a mean density of 30 5, (1-2) cells/mm2 that is a reduction by 53 and 51-3%, respectively. The two cases of PSP with mean cell numbers of 25 and 48 respectively, showed an average reduction of 60% versus controls. In SDAT; the number of large NPPc neurons was 65-1, 0-8 and the cell density was 41-5, (0-9)/mm2 which corresponds to a reduction by 28-9 and 29%, respectively. In Alzheimer's disease neuronal numbers of 59 4, (0 6) and density of 37*3, (0 7) cells/mm2 were reduced by 33-8 and 35 3% of controls (fig 1) 
Discussion
Neuronal loss of variable intensity associated with cytoskeletal changes (Lewy bodies, neurofibrillary tangles) have been reported in several subcortical nuclei in both Parkinson's and Alzheimer's diseases.'4-20 In Parkinson's disease neuronal loss in zona compacta-nigrae ranging from 66 to 85% is much more severe than in AD/SDAT showing 6% to 38% cell depletion. Cell loss in the noradrenergic locus coeruleus in both disorders ranges from 60 to 85%. In AD/SDAT topographic-arrangement of cell loss and its correlation to neuronal depletion and density of neuritic plaques in the temporal cortex suggest retrograde degeneration due to primary cortical damage;19 while no such correlation has been observed in Parkinson's disease. In the serotonergic dorsal raphe nucleus neuronal loss in Parkinson's disease averages 42-2%, but in AD/SDAT shows a wide range from 6% to 77% of controls,14 15 18 up to 90% of the remaining neurons showing fibrillary tangles.'8 Significant cell loss has been reported in the cholinergic nucleus basalis of Meynert in both Parkinson's disease and Alzheimer's disease/SDAT. 14 15 17 20 21 Cell depletion in-this nucleus is much higher in demented Parkinson's subjects, irrespective ofthe cortical pathology, where it approaches the values of Alzheimer's disease, than in non-demented Parkinson's disease patients where cholinergic-cell reduction is similar to the losses seen in SDAT.14 15 20 The pedunculopontine nucleus in Parkinson's disease Parkinson's disease plus Alzheimer's disease as compared with age matched controls,9 while no significant neuronal depletion was seen in cases of Alzheimer's disease.10 Lewy bodies were abundant in all cases of Parkinson's disease and Parkinson's disease plus Alzheimer's disease, but infrequent in controls, while neurofibrillary tangles were common in all cases of Parkinson's disease plus Alzheimer's disease and Alzheimer's disease/SDAT.9 10 Similar results were reported in both Parkinson's disease and PSP.1" In the present series a significant 60% neuronal loss with fibrillary tangles in 40% to 64% of the remaining neurons was seen in two cases of PSP. In Parkinson's disease there was a significant decrease in neuronal numbers and density by over 50%, with Lewy bodies affecting 6% to 39% of the remaining cells. NPPc neuronal loss averaging 34% and 29%, respectively, was much less severe in Alzheimer's disease and SDAT. In these disorders, it was accompanied by the occurrence of fibrillary tangles, the incidence of which in NPPc, however, was much less than in other subcortical nuclei, for examnple the dorsal raphe nucleus.18 These data suggest that putative cholinergic neurons of the PPNc are more selectively affected in Parkinson's disease and PSP, and could be related to disorders of motor performance and co-ordination in these disorders, while in Alzheimer's disease/SDAT this nucleus involved in somatic motor activities appears to be only mildly affected. Overactivity of the NPPc in experimental MPTP Parkinsonism12 showing rather selective damage to the zona compacta nigrae22 might indicate dysfunctions in the tegmentonigro-subthalamo-cortical pathways, the pathogenetic factors and clinical significance of which in Parkinson's disease and PSP are sti-ll unknown. In the latter disorder, severe involvement of PPNc has been suggested to contribute to some disorders of movement, sleep-wake cycles and cognitionl that are known to be characteristic in both Parkinson's disease and PSP. Understanding the mechanisms by which this cholinergic subcortical nucleus is related to motor disturbances and other dysfunctions in Parkinsonism could provide further insight into the pathophysiology of basal ganglia disorders.
